Share

October 01, 1996; 47 (4) VIEWS AND REVIEWS

Guidelines for physicians with patients on IFN beta-1b

The use of an assay for neutralizing antibodies (NAB)

Donald W. Paty, Donald Goodkin, Alan Thompson, George Rice
First published October 1, 1996, DOI: https://doi.org/10.1212/WNL.47.4.865
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
28

Share

Article Information

vol. 47 no. 4 865-866
DOI: 
https://doi.org/10.1212/WNL.47.4.865
PubMed: 
8857709
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 1, 1996.
Copyright & Usage: 
Copyright 1996 by Advanstar Communications Inc.

Author Disclosures

    1. Donald W. Paty, MD,
    2. Donald Goodkin, MD,
    3. Alan Thompson, MD and
    4. George Rice, MD
  1. Donald W. Paty, MD,
  2. Donald Goodkin, MD,
  3. Alan Thompson, MD and
  4. George Rice, MD
  1. From the Department of Medicine (Dr. Paty), Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada; the Department of Neurology (Dr. Goodkin), University of California at San Francisco; the Department of Neurology (Dr. Thompson), Institute of Neurology, Queen Square, London, UK; Department of Clinical Neurological Sciences (Dr. Rice), University of Western Ontario, London, Ontario, Canada.
  2. Drs. Paty, Goodkin, Thompson, and Rice served as paid consultants to Berlex Laboratories, Inc., but own neither stock nor equity in Berlex Laboratories, Inc. Supported by Berlex Laboratories.
  3. Received July 24, 1996. Accepted in final form July 26, 1996.
  4. Address correspondence and reprint requests to Dr Paty, Department of Medicine, Division of Neurology, University of British Columbia, S195, 2211 Westbrook Mall, Vancouver, BC V6T 2B5, Canada.
View Full Text

Article usage

Article usage: October 2007 to March 2021

AbstractFullPdfSource
Oct 2007022Highwire
Nov 2007011Highwire
May 2008010Highwire
Jun 2008011Highwire
Jul 2008011Highwire
Nov 2008001Highwire
Jul 2010001Highwire
Sep 2010011Highwire
Nov 2010001Highwire
Jan 2011010Highwire
Mar 2011020Highwire
Apr 2011001Highwire
Jun 2011001Highwire
Sep 2011021Highwire
Oct 2011100Highwire
Nov 2011001Highwire
Dec 2011300Highwire
Jan 2012201Highwire
Feb 2012010Highwire
Mar 2012200Highwire
Apr 2012100Highwire
May 2012700Highwire
Jun 2012400Highwire
Jul 2012300Highwire
Aug 2012101Highwire
Sep 2012400Highwire
Oct 2012200Highwire
Mar 2013003Highwire
Jun 2013100Highwire
Jul 2013200Highwire
Sep 2013100Highwire
Oct 2013211Highwire
Nov 2013200Highwire
Dec 2013100Highwire
Jan 2014100Highwire
Feb 2014100Highwire
Mar 2014100Highwire
Apr 2014200Highwire
May 2014102Highwire
Jun 2014400Highwire
Jul 2014100Highwire
Aug 2014100Highwire
Sep 2014201Highwire
Oct 2014400Highwire
Dec 2014300Highwire
Mar 2015500Highwire
Apr 2015600Highwire
May 2015501Highwire
Jun 2015801Highwire
Aug 2015800Highwire
Sep 2015100Highwire
Oct 2015100Highwire
Dec 2015200Highwire
Jan 2016600Highwire
Feb 2016100Highwire
Mar 2016200Highwire
Apr 2016400Highwire
Jun 2016200Highwire
Jul 2016100Highwire
Aug 2016100Highwire
Sep 2016400Highwire
Oct 2016100Highwire
Nov 2016100Highwire
Dec 2016201Highwire
Feb 2017401Highwire
Mar 2017100Highwire
May 2017100Highwire
Sep 2017100Highwire
Oct 2017001Highwire
Dec 2017110Highwire
Jan 2018110Highwire
Feb 2018210Highwire
Mar 2018500Highwire
Apr 2018200Highwire
Jun 2018200Highwire
Jul 2018300Highwire
Aug 2018210Highwire
Sep 2018200Highwire
Oct 2018900Highwire
Nov 2018701Highwire
Dec 2018800Highwire
Jan 2019400Highwire
Apr 2019300Highwire
May 2019600Highwire
Jun 2019100Highwire
Jul 2019200Highwire
Oct 2019710Highwire
Nov 2019500Highwire
Jan 2020200Highwire
Feb 2020510Highwire
Mar 2020410Highwire
Apr 2020300Highwire
May 2020300Highwire
Jun 2020300Highwire
Jul 2020200Highwire
Aug 2020200Highwire
Sep 2020300Highwire
Oct 20201600Highwire
Nov 2020810Highwire
Jan 2021220Highwire
Feb 2021230Highwire
Mar 2021610Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me